ORYZON receives the INNOVATIVE SME seal from the Spanish Ministry of Science and Innovati... 04/04/2024 Healthcare Access to innovation La compañía biofarmacéutica ya ha sido inscrita en el Registro de Público de PYMES INNOVADORAS. Partners - Oryzon Genomics
Celtarys Research, USC-biofarma and ZeClinics seek new therapeutic targets for Parkinson's... 01/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies This project, coordinated by Asebio, brings together ZeClinics' target validation and in vivo drug screening... AseBio
Almirall signs licensing agreement with Eloxx Pharmaceuticals and enters the field of rare... 25/03/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013. Partners - Almirall
The European Virtual Biotechnology Forum: Next Generation Sequencing Advancements and Ris... Online Del 03/04/2024 15:00 to 03/04/2024 17:10 Healthcare Access to innovation International Digitalization The European Biotechnology Forum: Next Generation Sequencing Advancements and Risks: Next-Generation-Sequencing (NGS)...
Spanish biotechnology leads the global fight against tuberculosis 24/03/2024 Healthcare Access to innovation Innovative drugs On the occasion of World Tuberculosis Day, we delve into the advances achieved by the candidate vaccine against... AseBio - Zendal
Almirall licenses an anti-IL-21 monoclonal antibody from Novo Nordisk to develop it as a f... 22/02/2024 Healthcare Access to innovation Drug discovery Innovative drugs NN-8828 is a first-in-class monoclonal antibody in dermatology with high affinity for the cytokine IL-21 that has been... Partners - Almirall
New developments in the detection of breast cancer and medical devices 21/02/2024 Healthcare Access to innovation This innovative project involves pioneering multicenter research using a new microwave imaging technique to enhance the... Partners - Fundación Teófilo Hernando (FTH)
LivingCells, the first bioincubator in Spain specialised in advanced therapies 20/02/2024 Access to innovation Advanced therapies 6 startups and 8 bioincubated projects already in progress 2.38 M euros raised in public aid Partners - PEACHES BIOTECH S.L.
LivingCells, the first bio-incubator in Spain specialised in advanced therapies 20/02/2024 Access to innovation Advanced therapies LivingCells accelerates those biomedical and biotech projects and startups, whose objectives are the development of new... Partners - PEACHES BIOTECH S.L.
AbilityPhama has completed the recruitment of the PanC-ASAP phase 2b clinical trial in pan... 16/02/2024 Healthcare Access to innovation Innovative drugs Efficacy results of the double-blind placebo-controlled trial will be available by the end of 2024. Partners - Ability Pharmaceuticals
